Thursday, August 17, 2017 3:23:29 PM
From NT 10Q filed a couple of days ago:
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ? No ?
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Precipio, Inc. (the “Company”) is modifying its response to Part IV – Other Information, Item (3) as indicated in its Form 12b-25 filed on August 14, 2017 to indicate that it does anticipate that a significant change in results of operations from the second quarter of 2016 will be reflected by the earnings statements to be included in the Form 10-Q for the second quarter of 2017 (the “Form 10-Q”) as a result of the Company’s merger with Precipio Diagnostics, LLC on June 29, 2017 (the “Merger”).
On July 31, 2017, the Company filed a Form 8-K/A that included the unaudited pro forma combined financial information of the Company following the Merger as of and for the three months ended March 31, 2017. The Company does not expect that there will be any significant change in results of operation in the Form 10-Q compared to such financial information included in the Form 8-K/A.
Recent PRPO News
- Precipio Announces Year end 2023 Shareholder Update Call • GlobeNewswire Inc. • 03/25/2024 09:00:00 PM
- Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY • GlobeNewswire Inc. • 02/13/2024 03:00:00 PM
- Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer • GlobeNewswire Inc. • 02/06/2024 03:00:00 PM
- Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter • GlobeNewswire Inc. • 01/23/2024 03:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/19/2024 09:05:44 PM
- Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan • GlobeNewswire Inc. • 01/17/2024 03:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:33:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:01:11 PM
- Precipio Announces Christina Valauri joins the Board of Directors • GlobeNewswire Inc. • 01/02/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:00:22 PM
- Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 • GlobeNewswire Inc. • 12/14/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:15:16 PM
- Precipio Announces Q3-2023 Shareholder Update Call • GlobeNewswire Inc. • 11/16/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:25 PM
- Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 • GlobeNewswire Inc. • 10/18/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:34:18 PM
- Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 • GlobeNewswire Inc. • 10/03/2023 02:00:00 PM
- Precipio Continues to Sign New HemeScreen™ Customers • GlobeNewswire Inc. • 09/28/2023 01:00:00 PM
- Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven • GlobeNewswire Inc. • 09/25/2023 03:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 09:10:33 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM